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Abstract
Background: To prevent harmful autoimmunity most immune responses to self proteins are controlled by central and
peripheral tolerance. T cells specific for a limited set of self-proteins such as human heat shock protein 60 (HSP60) may
contribute to peripheral tolerance. It is not known whether HSP60-specific T cells are present at birth and thus may play a
role in neonatal tolerance. We studied whether self-HSP60 reactive T cells are present in cord blood, and if so, what
phenotype these cells have.
Methodology/Principal Findings: Cord blood mononuclear cells (CBMC) of healthy, full term neonates (n = 21), were
cultured with HSP60 and Tetanus Toxoid (TT) to study antigen specific proliferation, cytokine secretion and up-regulation of
surface markers. The functional capacity of HSP60-induced T cells was determined with in vitro suppression assays.
Stimulation of CBMC with HSP60 led to CD4+ T cell proliferation and the production of various cytokines, most notably IL-10,
Interferon-gamma, and IL-6. HSP60-induced T cells expressed FOXP3 and suppressed effector T cell responses in vitro.
Conclusion: Self-reactive HSP60 specific T cells are already present at birth. Upon stimulation with self-HSP60 these cells
proliferate, produce cytokines and express FOXP3. These cells function as suppressor cells in vitro and thus they may be
involved in the regulation of neonatal immune responses.
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Introduction
The immune system possesses a range of safekeeping mechanisms
that prevent the induction of a deleterious response to self-antigens.
First through negative thymic selection (central tolerance), by which
T cells expressing a T cell receptor with a high affinity for self
proteins are eliminated [1]. Secondly, self reactive T cells that do
escape central tolerance and develop into mature T-cells are kept
under control through peripheral tolerance [2]. One of the most
prominent mechanisms of peripheral tolerance is mediated by
regulatory T cells. Regulatory T cells (Tregs) suppress effector T cell
responses in vitro and can down regulate an ongoing immune
response in vivo [3]. They appear essential for the homeostasis of the
immune system as deficiencies in Treg numbers and/or function
lead to inflammatory diseases both in mice and in humans [4–6]
and are already present at the start of life [7,8]. Tregs are either
directly derived from the thymus or generated in the periphery.
Although the antigen specificity of Tregs is still largely unknown, it is
assumed that they can act through recognition of self-antigens in the
periphery [9]. This fits the premise that the immune response to
certain self-antigens is important for the regulation of immune
responses [10]. Cohen was the first to propose that the response to
a vested group of self-antigens is important for maintaining
peripheral tolerance [11]. He described the response against this
limited set of self molecules in a healthy individual, formed by auto
reactive T cells and antibodies as the immunological homunculus.
This ‘homunculus’ of self-antigens shares various properties, among
which evolutionary conservation between the self and the non-self
homologue of these proteins. One of these self proteins is human
heat shock protein 60 (HSP60) [12]. HSP60 is an evolutionary
highly conserved cellular protein. Also, it is a stress protein and acts
as a danger signal for the immune system: the expression of HSP60
is strongly up regulated following cellular stress, e.g. because of
tissue damage during inflammation [13,14]. HSP60 can activate
both adaptive and innate immune responses [15,16] which
underscores that HSP60 has the potential to be a regulator in an
inflammatory response. This is further supported by the observation
that in both animal and human in vitro studies HSP60-reactive
T cells have a strong immune modulatory capacity [17–19]. In
experimental models these HSP60-specific T cells can effectively
suppress in vivo a variety of experimental autoimmune diseases.
These findings have lead to the set up of several clinical trials using
HSP peptides, e.g. in rheumatoid arthritis (RA) and diabetes type I,
with promising results [20–22].
Thus, apparently, responses to HSP60 are important for
maintaining peripheral tolerance in the adult immune system.
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It is unknown when during live these specific T cells arise. It would
seem reasonable to expect that they are primed after birth upon
encounter with homologous microbial HSP in the gut [12].
However, there are indications that self-HSP60 reactivity is
present at birth. As early as 1991 it was shown that cord blood
cells proliferate in response to an in vitro challenge with the self
antigen HSP60 [23,24] and hypothesized that this reactivity is part
of the normal naı¨ve immune repertoire. A more recent study by
Merbl et al [25] put these findings in a different perspective. They
found that normal cord blood contains IgM and IgA autoanti-
bodies directed against a relatively uniform set of autoantigens,
such as autoantigens that are associated with autoimmune disease
(such as double stranded DNA) and autoantigens related to
immune regulation such as HSP60. The authors of this study
suggested that this obviously benign autoimmune self reactivity,
present already at birth, may have a dual function. On the one
hand it may provide the basis for autoimmunity in later life, while
on the other hand the ‘‘inborn’’ autoimmunity to regulatory self
antigens such as HSP60 may actually serve to protect against
autoimmune disease. Intrigued by these studies, we questioned
whether CD4+ T cells specific for HSP60 are already detectable at
birth before exposure to the microbial flora, and if so, to what type
of immune response these ‘‘inborn’’ autoreactive CD4+ T cells
have upon exposure to the self antigen HSP60. We found that
HSP60 specific T cells are indeed present at birth. Moreover,
stimulation of CBMC with HSP60 leads to CD4+ T cell
proliferation and cytokine production, and induces T cells with
an in vitro regulatory phenotype that are functionally suppressive.
Results
HSP60 induces CD4+T cell proliferation in cord blood
To detect possible HSP60-specific T cells in cord blood, we first
set out to study whether in vitro activation of CBMC with (human)
HSP60 induces T cell proliferation. First, using thymidine
incorporation we found that five of ten (50%) cord blood samples
showed a clear proliferative response to HSP60 (median Stimula-
tion Index (SI): 2.0; Inter Quartile Range (IQR): 2.5). Though we
used a very pure batch of human HSP60 for these experiments
with undetectable LPS levels (see methods) it is still conceivable
that contamination of extremely low levels may have influenced
these assays. We therefore wanted to confirm these preliminary
proliferation data using two peptide epitopes from HSP60. We
have shown before that these (panDR binding-) epitopes can
induce T cell proliferation in a majority of patients with JIA and
RA [26]. Sixty percent of the cord blood samples (three of five)
responded to either one or both peptides tested (SI.1.7). These
responses were also significantly different (p = 0.038) compared to
the proliferative response of TT, which was used as a negative
control, assuming that the fetus has not formed a prior response to
TT. No significant proliferation was seen in response to tetanus
toxoid (TT) compared to background. (Figure 1a).
Though this assay showed T cell proliferation to HSP60 we next
wanted to confirm this with CFSE staining, which allowed us to
determine which cells were dividing upon HSP60 stimulation. We
found that indeed CD4+ T cells proliferated specifically after
HSP60 stimulation in all samples (Figure 1b and 1c). Thus, HSP60
induced proliferation of cord blood derived CD4+ T cells.
To identify if these responses of CBMC and CD4 T cells could
be the result of HSP60 acting as a ligand for TLR2 or TLR4, as
previously suggested, we also performed these proliferation assays
in the presence of a TLR2 and/or a TLR4 blocking antibody, or
IgG isotype control (Figure S1). No differences in HSP60-induced
proliferation were found in the presence of TLR blocking
Figure 1. Human HSP60 (HSP) induces cell proliferation in cord
blood. A) Protein-induced proliferation of cord blood mononuclear cells
(CBMC). CBMC were cultured for 96 hours in the presence of Human
HSP60, the full protein as well as HSP60-derived peptide and Tetanus
Toxoid (TT). Box whisker plots are shown and significant differences in
responses are indicated with * (p,0.05). Background (mean +/2 SD):
1395 +/2 1446 CPM. Data (n= 10) were obtained from 4 independent
experiments. B) Protein-induced proliferation of cord bloodmononuclear
cells (CBMC) cultured in the presence of CFSE. CBMC were cultured for
144 hours and afterwards stained for CD4. HSP60 proliferation is
represented in lighter grey. Percentage indicates number of divided
CD4+ T cells. Data are representative for 3 independent experiments. C)
Protein-induced proliferation of cord blood mononuclear cells (CBMC)
cultured in the presence of CFSE. Box whisker plots are shown. Data
(n= 3) are obtained from 3 independent experiments.
doi:10.1371/journal.pone.0024119.g001
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antibodies suggesting that the observed proliferation of CBMC in
response to HSP60 is TLR2 and TLR4 independent.
Cytokine production in cord blood stimulated cells
We next wanted to know whether stimulation with HSP60 also
led to cytokine production by CBMC. Therefore, cytokine levels in
culture supernatants after 96 hours of stimulation with HSP60, TT
or medium alone were measured with a multiplex immune assay.
We found that, compared to stimulation with medium, HSP60-
induced production of IL-10 (p = 0.009), IL-5 (p = 0,013) IL-6
(p = 0.003), IL-13 (p = 0.003), TNF-alpha (TNFa) (p = 0.003) and
IFN-gamma (IFNc) (p = 0.005) were significantly increased. TT
induced a significant increase of IL-6 (p = 0.045) compared to
stimulation with medium (Figure 2a). To establish which cells are
producing IL-10 and IFNc, we next measured intracellular cytokine
production by FACS, again after stimulation in vitro with medium,
HSP60 and TT. We found an increased intracellular expression of
mainly IL-10, and also IFNc, by CD4+ T cells (Figure 2b and 2c),
after stimulation with HSP60 only (and not with TT). Thus,
stimulation of CBMC with HSP60 leads to proliferation and
cytokine production (IL-10 and IFNc) of CD4+ T cells.
HSP60-specific induction of regulatory T cells
There are indications that HSP60, and/or peptides derived
from HSP60 may induce or enhance the regulatory T cell
population. We therefore wanted to know whether HSP60 may
also play a role in T cell regulation at this crucial period at, or even
before birth. We therefore stimulated cells again with TT, HSP60
or medium and next stained the cells for expression of CD4,
CD30, CD45RO (memory T cells) and FOXP3. FOXP3 is a
transcription factor that is characteristic for Tregs. CD30 is an
activation marker that has been suggested to be a marker for Th2
cells, whereas we recently found that CD30 is upregulated on
antigen-induced Tregs [27]. As can be seen in figure 3a, following
stimulation with HSP60 we found a significant increase of
CD4+CD30+and CD4+CD45RO+as well as an increase of
Figure 2. Cytokine production induced by human HSP60 (HSP) in cord blood cells. A) Cells were cultured with human HSP60 or Tetanus
Toxoid (TT) for 4 days. Cytokine levels in supernatant of the cultures were measured using a multiplex immunoassay. Levels of cytokines are
presented in a histogram plot. HSP stimulated cells in white, and TT stimulated cells in light grey are compared to only medium cultured cells in black.
The supernatants (n = 7) were obtained in 3 independent experiments. Cytokine production was measured in one assay. B) Percentage IL-10+ and
IFNc+ CD4+ T cells following stimulation with human HSP60. Box whisker plots are shown and significant differences in responses are indicated with
* (p,0.05). Data (n = 4) were obtained from 2 independent experiments. C) A representative FACS-analysis of two independent experiments (n = 4)
showing intracellular IFNc and IL-10 staining of CD4+ T cells following stimulation with human HSP60.
doi:10.1371/journal.pone.0024119.g002
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CD4+FOXP3+cells, which is not seen after stimulation with
control antigen TT. The FOXP3+ expression was found in about
50% of the CD30+ and 25% of the memory T cells and not in
CD45RO- T cells (Figure 3b and 3c).
HSP60 induced regulatory T cells are functionally
suppressive
We next questioned whether these induced Tregs were
functional and thus have in vitro suppressive capacity. Therefore
we performed CFSE dilution - suppression assays, in which we
added HSP60 induced Tregs (CD4+CD25+CD1272 T cells) and
CFSE-labeled effector cells in different ratios. The HSP60-induced
Tregs were able to functionally suppress the effector T cells.
Compared to the proliferating CD4+ T cells we saw a decreasing
percentage of proliferating cells (figure 4a). After adding HSP60-
induced Tregs to the effector T cells in Treg:Teff ratios of 1:2; and
1:1 the percentage of suppression of proliferating CD4+ T cells
increased from respectively 41.3 to 56.6%. This indicates that
HSP60 induced CD4+CD25+CD1272 T cells are functional
suppressor cells in vitro.
Discussion
With this study we show that in cord blood HSP60 induces
CD4+ T cells that proliferate and produce various cytokines, most
notably IL-10 and IFNc. Moreover such HSP60-induced T cells
Figure 3. Human HSP60 (HSP) induces CD30 and the expression of Foxp3 in cord blood. CD4+ T cells after stimulation for 6 days. A) FACS
analysis shows a significant higher level of CD4+CD45RA+, CD4+CD45RO+ and CD4+CD30+ T cells as well as CD4+FOXP3+ T cells following stimulation
with HSP60. Box-Whisker plots are shown and significant differences in responses are indicated as * (p,0.05). Data (n = 7) were obtained from 3
independent experiments. B) FACS analysis of FOXP3 expression within the CD4+CD30+ and CD4+CD45RO+ populations following HSP60 stimulation.
Data (n = 7) were obtained from 3 independent experiments. C) FACS analysis representing data (n = 7) from 3 independent experiments of CD4+ T
cells expressing FOXP3 after stimulation with human HSP60, showing that most FOXP3 positive CD4 T cells also express CD45RO and half of them
express CD30.
doi:10.1371/journal.pone.0024119.g003
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express CD30, CD45RO and FOXP3, and act as suppressor
T cells in vitro. These findings underscore the universality and thus
presumed importance of the ‘‘inborn’’ recognition of self proteins,
like HSP60, early in life.
A healthy immune system is able to initiate as well as regulate
inflammation, while maintaining tolerance for self-antigens. Im-
mune responses to certain self proteins are hypothesized to be
important for a healthy immune system [28]. These ‘‘immunolo-
gical homunculus’’ proteins, among which stress proteins like
HSP60, may serve as immune biomarkers to the body educating the
immune system on the state of present inflammation. Our results
would fit this hypothesis, as it suggests that an immune response to
self HSP60 is part of an ‘‘inborn’’ mechanism present already at
birth that may help to regulate inflammation. It can be speculated
that human HSP60 could be regarded as a recall antigen in the
fetus, as self proteins are probably continuously present in the
developing fetus due to apoptosis of developing tissues. This may
contribute to induction of a (tolerogenic) response to self proteins
like HSP60 before birth and may explain why HSP60 in cord blood
elicits such evident responses as seen in our study.
Interestingly, HSP60 has previously been identified as a potent
regulator of inflammation in the adult immune system. In the end of
the 80’s human HSP60 was found to be recognized by the immune
system during inflammation. It was then shown that HSP60-specific
T cells can dampen experimental autoimmune disorders, while in
humans HSP60 is recognized by healthy individuals free of
autoimmune disease or infection [29]. The capacity of HSP60 to
induce both innate and adaptive immunity indicates that HSP60
has a double function: responsiveness to HSP60 can be related to
inflammation, but also to a healthy immune system. Next it was
shown in human studies that HSP60-specific immune responses in
patients with juvenile arthritis (JIA) and RA are associated with
a better prognosis and milder symptoms, again suggesting a role in
regulating inflammation [30]. In line with these findings we now
show that HSP60-specific T cells are present at birth which
underscores the hypothesis that auto-reactive T cells are a principal
feature of a healthy immune system.
In addition to the finding that in cord blood HSP60 can induce
FOXP3+ regulatory T cells, that are functionally suppressive, we
have shown that HSP60 leads to the induction of IL-10 and IFNc,
suggesting the upregulation of Tr1 cells. We have also shown that
HSP60 leads to the induction of Th2 cytokines (IL-5 and IL-13)
confirming that an immune response in cord blood is primarily
a Th2 response. Another interesting finding is the huge increase of
IL-6, as well as an increase in TNFa. IL-6 has been reported as
a Th2 inducer and an important anti-inflammatory cytokine,
aiding in the protection of the fetus in utero [31]. Both TNFa and
IL-6 however have also been shown to be upregulated by TLR
agonists in cord blood. Our experiments with HSP60 peptides and
our experiments in which we block TLR2 and TLR4 indicate that
stimulating with HSP60 induces an antigen specific response. In
conclusion, functional HSP60 specific CD4+ cells are already
present at birth before priming of the immune cells with the
microbial flora in the gut. This mechanism may be important for
the maintenance of prenatal and neonatal immune tolerance.
Materials and Methods
Collection of cord blood
Cord blood samples (n = 21) were collected from healthy
subjects at the department of gynecology and obstetrics. Inclusion
criteria were an uncomplicated pregnancy, full-term infant and
normal vaginal delivery. No further information about the mother,
pregnancy or the delivery was obtained. Written informed consent
was obtained. This study was approved by the Medical Ethics
Committee, UMC Utrecht (NL16498.041.07).
Isolation of CBMC
Cord blood mononuclear cells (CBMC) were isolated from
heparinised venous blood by Ficoll (Pharmacia, Uppsala, Sweden)
density gradient centrifugation. The cells were then frozen in
liquid nitrogen and thawed prior the experiment. The culture was
performed in RPMI-1640 supplemented with 2 mM glutamine,
100 u/ml of penicillin/streptomycin (Gibco BRL, Gaithersburg,
MD) and 10% (v/v) ABpos heat-inactivated (60 min at 56u
Celsius) human serum (Sanquin, Amsterdam, the Netherlands).
For measurement of the proliferative activity, 26105 cells in 200 ml
per well were cultured in triplicate in round bottomed 96-wells
plates (Nunc, Roskilde, Denmark) for 96 hours at 37u Celsius in
5% CO2 with 100% relative humidity. Cells were cultured in the
absence or presence of 10 mg/ml human HSP60, both the full
Figure 4. Human HSP60 (HSP)-induced CD4+CD25+ cord blood T cells suppress proliferation of T effector cells. Different amounts (0,
10.000 or 20.000) of sorted HSP60-induced regulatory T cells were cultured with 20.000 CFSE labeled effector T cells for 5 days in the presence of
plate-bound anti-CD3. A) A CFSE dilution profile of effector T cells alone (open histogram) or in the presence of HSP60-induced Tregs at a ratio of 1:1
(closed histogram). This figure represents data (n = 3) from 2 independent experiments. B) Percentages suppression measured by CFSE dilution. Data
(n = 3) are obtained from 2 independent experiments.
doi:10.1371/journal.pone.0024119.g004
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protein as two peptides p2 (human HSP60 peptide 280–292) and
p4 (human HSP60 peptide 242–256) [22]. The highest response to
either peptide was scored. The LPS-content of HSP60 was ,0.1
EU/mg protein. Tetanus-toxoid (TT; 1.5 mg/ml, RIVM, Biltho-
ven, the Netherlands) was used as a negative control, assuming
that the fetus has not formed a prior response to TT. For the final
16 hours of culture, 1 mCi/ well [3H] thymidine (ICN Biomedi-
cals, Amsterdam, the Netherlands) was added to each well. Cells
were harvested according to standard procedures and incorpo-
rated radioactivity was measured by a liquid scintillation counter
and expressed as counts per minute (cpm). The magnitude of the
proliferative response is expressed as stimulation index, which is
the mean cpm of cells cultured with antigen divided by the mean
cpm of cells cultured without the antigen.
TLR-blocking assay
Isolated CBMC were cultured for 96 hours in the presence or
absence of 10 mg/ml human HSP60 and in the presence or
absence of anti-TLR4 blocking antibody (2.5 mg/ml, clone
HTA125, Serotech), anti-TLR2 blocking antibody (2.5 mg/ml,
clone TL2.1, Serotech), both, or IgG2a isotype control (2.5 mg/ml,
Serotech). Proliferation was measured as described above.
CFSE assay
To characterize which cells proliferate to HSP60, CFSE-assays
were performed. For this purpose 3 mM CFSE was added to
16106 CBMC for ten minutes and washed twice with 10% FCS.
CBMC were resuspended in human AB 20% and stimulated with
HSP60 for 6 days. Cells were then stained with anti-CD3, -CD4
and -CD14 and analyzed by FACS Calibur (Becton Dickinson
Biosciences, San Jose, CA, USA), as described below.
Multiplexed particle-based immuno assay
Cytokine levels were measured after activation of the lymphocytes
in vitro as described above. After 96 hours the supernatants of the
cell cultures were stored at280uC. Cytokines levels of IL-4, IL-5, IL-6,
IL-10, IL-12, IL-13, IFNc and TNFa were measured with the Bio-
Plex system and analysed with the Bio-Plex Manager software version
4.0 (Bio-rad Laboratories, Hercules CA, USA) which uses the
Luminex xMap technology [32]. The cytokine production is presented
in a color profile to visualise the different cytokines produced.
FACS staining
CBMC were stimulated for 6 days with HSP60 and TT and then
washed twice in PBS containing 2% FCS (PBS-FCS) and blocked
with the appropriate normal serum (30 min at 4uC). Subsequently,
the cells were incubated in 50 ml of FACS buffer containing four
appropriately diluted PE-, FITC-, PerCP-, or allophycocyanin-
labeled mAbs against human CD4 (clone SK3) (Becton Dickinson
Biosciences), CD30 (clone BER-H8) (Becton Dickinson Bios-
ciences), CD45RA (clone JS-83) (eBioscience, San Diego, CA,
USA), CD45RO (clone 4CHL-1) (eBioscience, San Diego, CA,
USA) and FOXP3 (PCH101) (eBioscience, San Diego, CA, USA).
Stained mononuclear cells were diluted in FACS fluid and run on a
FACS Calibur (Becton Dickinson Biosciences). CellQuest software
(Becton Dickinson Biosciences) was used for analysis.
Cytokine analysis by lymphocyte intracellular staining
and flow cytometry
CBMC were stimulated as described above. During the last
4 hours of culture, Golgistop (Becton Dickinson Biosciences) was
added (final concentration of 2 mM). The cells were harvested and
stained for intracellular cytokine and FOXP3 analysis as described
previously. For the staining, a predetermined optimal concentration
of PE-conjugated anti-IL-10 (clone JES3-19F1), FITC-conjugated
anti-IFNc (clone 4S.B3) (Becton Dickinson Biosciences) and APC-
conjugated FOXP3 (eBioscience, San Diego, CA, USA) was added
to the cells. Cells were analysed as described above.
Suppression assay
To examine the functionality of induced regulatory T cells,
CBMC were thawed and CD25 positive cells were depleted. The
CD25 negative cells were stimulated with HSP60 for 6 days. Effector
T cells (thawed CBMC of the same donor) were stained with CFSE
(3 mM). With a FACS sorter added different numbers of CD4+
CD25+CD127- (regulatory) T cells were added to the 20.000 effector
T cells, depending on availability of cells. In every experiment we
included at least the Teff:Treg ratios 1:0, 2:1 and 1:1. The different
ratios were incubated for 120 hours in the presence of plate-bound
anti-CD3 (1 mg/ml) and with the FACS diva the percentages of
proliferation and suppression were measured.
Statistical analysis
Basic descriptive statistics were used to describe the patient
population. A non-parametric test (Mann Whitney U test, 2 sided)
and where appropriate a parametric test (T-test, 2 sided) was
applied to determine significant differences between the stimuli
and the controls regarding proliferative responses, cytokine
production and expression of surface markers and intracellular
markers. A p-value ,0.05 was considered significant (SPSS
Statistical Program, version 15.0; SPSS Inc, Chicago, Ill.)
Supporting Information
Figure S1 Human HSP60 induced cell proliferation of
CBMC, with or without anti -TLR2 and/or TLR4
blocking antibodies, or IgG isotype control. Shown are
mean stimulation index (relative to medium conditions) 6 SEM.
Data (n = 6) are obtained from 2 independent experiments. NS =
non-significant.
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